Role of androgens in male pseudoheraaphroditism. Studies in a large Arab kindred revealed 23 male pseudohermaphrodites due to 17 e-hydroxysteroid dehydrogenase deficiency. All individuals were reared as females even though their external genitalia were mild to moderately ambiguous at birth. At puberty. male body habitus with normal secondary sexual characteristics developed. Gynecomastia was absent. The phallus and testes enlarged to adult proportions and a spontaneous change to male gender role occured in several individuals. The biochemical defect was demonstrable only after puberty and consisted of greatly elevated 64-androstenedione (300-1300 ng/dl) with relatively low testosterone levels (0.7-3 ng/ml). Dehydroepiandrosterone levels were either normal or moderately elevated while 17 a-estradiol was elevated (36-130 pg/ml). LH and FSH levels were very high postpuberty, but normal before. However, there was overresponse to LIIRH in sll age groups.
reviewed in 6 girls with 21-hydroxylase deficiency (3 salt-losers). Mean age at menarche was 13.6 yr (12.6-14.5), body weight varied from 45 to 6 6 kg. Menarche did not occur with plasma testosterone (T) levels of 5-6 nmol/L. Normal female plasma T levels occurred on chang ing from hydrocortisone to single dose dexamethasone (dex) given as 0.25 to 0.75 mg/day. The potency of dex relative to cortisol was 60:1 based on adrenal suppression effect . Regular menses occurred with plasma T levels in the normal female range.
Ovulatory cycles were documented using menstrual profiles of salip rogesterone (P) performed at a post-menarchal age of 3.0-3.4 yr. Some showed the characteristic r~se in luteal levels of saliva l7p indicating previous ovulation; one 16 yr old girl became pregnantÃ novula tory cycles also occurred in well-controlled girls . Preliminary data on controls showed absence of ovulatory cycles for at least 2 yr post-menarche. Conclusions: in CAB, 1) Menarche is not usually delayed. 2) OVUlatory cycles may be delayed but further control data is needed~3) Normal plasma T levels are reqUired for regular menses. 4) This can be achieved using single dose dex~therapy. Dissociation of secretion of cortisol and AA, observed in several physiologic and pathologic conditions, has led to the hypothesis that secretion of AA may be controlled by another hormone in addition to ACTH. An alternate hypothesis attempts to explain all instances of such dissociation by changes in ACTH alone, wherein ACTH controls synthesis of AA by changing the intraadrenal concentration of cortisol. This hypothesis does not allow for dissociation of cortisol and AA in a subject with normal ACTH secretion and intact adrenals . To test this hypothesis, we studied cortisol secretion in 4 pat ients (20 -26 years) with idiopathic hypopituitarism (who never received cortisol replacement therapy) and deficiency of AA as reflected by lack of adrenarche and low levels of serum DHEAS. Determination of serum cortisol and l7-0H progesterone (17 OHP) at 2 h intervals for 2 days and of cortisol and 17 OHP responses to insulin induced hypoglycemia and glucagon infusion revealed nOrmal cortisol and 17 OHP secretion in 2 of the 4 patients . Although intraadrenal concentrations of cortisol and serum levels of ACTH were not measured, there is no reason to suspect that these levels should be abnormal in the 2 patients who had normal cortisol secretion. Low serum levels of DHEAS in these patients cannot be explained by deficiency of ACTH secretion . Our data provide further evidence that secretion of AA aay be controlled by another horaone in--'dition to ACTH. Adrenal salt-wasting diseases in the neonatal period and early infancy can be confirmed by the pattern of steroids excreted in urine. The presence or absence of cortisol, aldosterone and corticosterone metabolites, plUS certain precursors, is established in a single analysis of steroids using gas chromatography with ca pi l l ary columns and mass spectrometry.
In infants (n=5) with t he Type II biosynthetic defect of aldosterone, the excretion of cort icosterone and 18-hydroxycorticosterone metabolites were elevated. In PHA (n=8), both 18-hydroxycorticosterone and aldosterone metabolites were found at hi gh concentrations in urine. When salt loss was controlled by replacement therapy or sodium supplements respectively, and plasma renin activity (pRA) were normalised, the excretion rates of the metabolites were lower but the ratios of excretion for 18-hydroxycorticosterone to aldosterone metabolites were greater than 30 to 1 in the biosynthetic defect but nearer unity in PHA. The interpretation of the overall pattern of steroid excretion also requires consideration of the changes in t he nature of steroid metabolites in newborns through infancy, since conjugates of tetrahydro-metabolites replace hydroxylated and free compounds. These studies are complementary to determinations of pRA and plasma steroid concentrations in defining the diagnosis of infantile salt wasting disease. Purified carrier-free IOOnoiodinated insulin (Ins") alone or mixed with an excess of native insulin was injected into the vitelline vein of 17, 19 or 21 day-post coitum (d.,P.c.) rat fetuses in utero. Several organs concentrated Ins" among wlUch liver, kidneys, heart, jejuno-ileum and lungs. Their radioactiVity vas analyzed by gel chromatography and autohistoradiography. In the 3 age groups, the liver had the highest specific activity: binding was saturable, partly reversible, associated with the hepatocytes and to a lower extent with the liver hematopoietic cells. Liver _turation was essentially characterized by a progressively increasing rate of hormone internalization and degradation. In the lungs, high affinity and saturable binding was associatsd with the glycogen-laden cells of the bronchial tubes (pseudoglandular stage: 17 d.p.c. fetuses). Ins" binding was no longer observed in more mature surfactant synthetizing cells (canalicular, 19 d.p.c . and alveolar, 21 d.p .c. stages ). In conclusion: 1 . Insulin receptors ontogenesis occurs early in gestation. 2. During the last 5 days of intra-uterine life, cytodifferentiation differently affects insulin metaboliSID at the cellular level, inducing loss of insulin receptors (lungs) or maturation of poIIt receptor steps (hepatocytes).
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The aim of this study was to determine whether RBC insulin receptor assay represents an useful means for assessment of the clinical sensitivity of insulin. Steady State Plasma Glucose(SSPG) was established by constant infusion of somatostatin(125pg loading followed by l25pg/~/hr), glucose (6mg/kg/min) and insulin(0.8 mU/kg/min) . Insulin binding to RBC receptors was measured and compared with SSPG. Insulin binding to RBC was assayed by the modified method of Gambhir. Plasma insulin area was measured by GTT. A decreased specific insulin binding(SB) to RBC, due to reduced receptor concentrations was observed in hyperinsulinemic obese children. In 21 children with various body weights, SB was inversely related to fasting plasma insulin level (r=-0.65l, p<;O.Ol) and also with plasma insulin area Ir=-0.547, p<:O.Ol) . A highly significant inversed correlation was noted between SSPG and SBlr=-0 .807, p<: 0.005). SSPG was, also, correlated with the fasting plasma insulin level(r=0.669, p-e0.05). It was concluded that RBC insulin receptor is an useful tool for cJinical evaluation of tissue insulin sensitivity.
